Home > Insider Trading > Filing (0001415889-22-002576)

Filing Details

Accession Number:: 0001415889-22-002576
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-04 18:14:00
Reporting Period:: 2022-03-02

Accepted Time:: 2022-03-04 18:14:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	Services-Offices & Clinics Of Doctors Of Medicine (8011)	043705970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780955	Mala Murthy	C/O Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-03-02	2,677	$0.00	20,034	No	4	M	Direct
Common Stock	Acquisiton	2022-03-02	4,552	$0.00	24,586	No	4	M	Direct
Common Stock	Acquisiton	2022-03-02	1,146	$0.00	25,732	No	4	M	Direct
Common Stock	Acquisiton	2022-03-02	2,485	$0.00	28,217	No	4	M	Direct
Common Stock	Acquisiton	2022-03-02	1,880	$0.00	30,097	No	4	M	Direct
Common Stock	Disposition	2022-03-03	6,717	$70.24	23,380	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2022-03-02	2,677	$0.00	2,677	$0.00
Common Stock	Performance Stock Units	Disposition	2022-03-02	4,552	$0.00	4,552	$0.00
Common Stock	Performance Stock Units	Acquisiton	2022-03-02	2,290	$0.00	2,290	$0.00
Common Stock	Performance Stock Units	Disposition	2022-03-02	1,146	$0.00	1,146	$0.00
Common Stock	Restricted Stock Units	Disposition	2022-03-02	2,485	$0.00	2,485	$0.00
Common Stock	Performance Stock Units	Acquisiton	2022-03-02	5,637	$0.00	5,637	$0.00
Common Stock	Performance Stock Units	Disposition	2022-03-02	1,880	$0.00	1,880	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,678	No	4	M	Direct
4,552	No	4	M	Direct
2,290	No	4	A	Direct
1,144	No	4	M	Direct
4,972	No	4	M	Direct
5,637	No	4	A	Direct
3,757	No	4	M	Direct

Footnotes

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
On March 2, 2020, the reporting person was granted 8,033 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 2, 2021, the reporting person earned 13,656 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021.
The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022.
On March 2, 2022, the reporting person earned 2,290 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
On March 2, 2021, the reporting person was granted 7,457 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
Performance award amount determined based on metrics in respect of the issuer's 2021 financial results
The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022.
On March 2, 2022, the reporting person earned 5,637 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.